Log in to save to my catalogue

Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Ca...

Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Ca...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2579087565

Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Cancer

About this item

Full title

Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Cancer

Publisher

England: by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology

Journal title

International journal of gynecological cancer, 2016-05, Vol.26 (4), p.671-679

Language

English

Formats

Publication information

Publisher

England: by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology

More information

Scope and Contents

Contents

OBJECTIVEIncreased numbers of tumor-infiltrating lymphocytes (TILs) in high-grade serous ovarian cancer (HGSC) are associated with improved clinical outcome. Intraepithelial localization of TILs might be regulated by specific homing receptors, such as CD103, which is widely expressed by intraepithelial lymphocytes. Given the emerging role of CD103...

Alternative Titles

Full title

Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2579087565

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2579087565

Other Identifiers

ISSN

1048-891X

E-ISSN

1525-1438

DOI

10.1097/IGC.0000000000000672

How to access this item